(Foreword: This thread is meant to be fun. Let's try our best to keep the bickering, name-calling, whining, and unbounded stupidity the hell out of it.)
Now..., it seems, mid-2011, with Histogen's H.S.C. (and a few other such efforts), and ACell (and a few other such endeavors, there, too, such as that of working with follicle-transection), one may observe a sort of "race" between figuring out how to remove the restriction of a limited donor-supply, from surgical hair-transplantation; and developing a compound that will stop balding and restore a respectable (ideally, total) number of already-lost hairs.
This is a poll-thread, of course, so let's just get started: pick your horse, and place your wager —
!
Now..., it seems, mid-2011, with Histogen's H.S.C. (and a few other such efforts), and ACell (and a few other such endeavors, there, too, such as that of working with follicle-transection), one may observe a sort of "race" between figuring out how to remove the restriction of a limited donor-supply, from surgical hair-transplantation; and developing a compound that will stop balding and restore a respectable (ideally, total) number of already-lost hairs.
This is a poll-thread, of course, so let's just get started: pick your horse, and place your wager —

Comment